After a dozen years at the helm of Merge Technologies, PACS and connectivity veteran Bill Mortimore has turned over the reins to Richard Linden. The move comes as part of a management restructuring that makes Linden president and CEO and Mortimore
After a dozen years at the helm of Merge Technologies, PACS and connectivity veteran Bill Mortimore has turned over the reins to Richard Linden. The move comes as part of a management restructuring that makes Linden president and CEO and Mortimore chairman and chief strategist.
In addition to founding Merge in 1987, Mortimore is one of the original members of the American College of Radiology/National Electrical Manufacturers Association (ACR/NEMA) committee responsible for establishing and maintaining the DICOM medical imaging standard. He also serves as chair of the Medical Imaging Informatics Section of NEMA and as a member of the board of directors of NEMAs diagnostic imaging division.
Under Mortimores leadership, Merge Technologies has moved from OEM-focused product distribution to a combination of OEM, value-added reseller, and direct sales. In addition, the firm has increased its core connectivity product portfolio (enabling the exchange of data in standard HL7 and DICOM formats between disparate legacy systems) to include Java-based text and image data exchange.
In his new position at Merge, Mortimore will turn his attention to advancing the strategic business and financial strategies of the Milwaukee-based firm, with particular emphasis on moving the company beyond its traditional clinical base into the broader healthcare environment.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.